Evotec Q1 EPS $(0.07) Beats $(0.10) Estimate, Sales $226.69M Beat $222.57M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evotec (NASDAQ:EVO) reported Q1 earnings per share (EPS) of $(0.07), beating the analyst estimate of $(0.10) by 35%. Sales were $226.69M, surpassing the $222.57M estimate. Despite the beats, both EPS and sales showed declines compared to the same period last year.
May 22, 2024 | 5:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evotec reported better-than-expected Q1 EPS and sales, but both metrics declined year-over-year. The EPS of $(0.07) beat the $(0.10) estimate by 35%, and sales of $226.69M beat the $222.57M estimate by 1.85%. However, EPS decreased by 62.5% and sales by 1.09% compared to the same period last year.
The better-than-expected EPS and sales figures are likely to have a positive short-term impact on Evotec's stock price. However, the year-over-year declines in both EPS and sales may temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100